Concord Biotech Ltd Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CONCORD BIOTECH LTD, and what generic and branded alternatives to CONCORD BIOTECH LTD drugs are available?
CONCORD BIOTECH LTD has four approved drugs.
Summary for Concord Biotech Ltd
US Patents: | 0 |
Tradenames: | 3 |
Ingredients: | 3 |
NDAs: | 4 |
Drug Master File Entries: | 16 |
Drugs and US Patents for Concord Biotech Ltd
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Concord Biotech Ltd | MYCOPHENOLIC SODIUM | mycophenolic sodium | TABLET, DELAYED RELEASE;ORAL | 211173-002 | Dec 13, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
Concord Biotech Ltd | TACROLIMUS | tacrolimus | CAPSULE;ORAL | 213112-001 | Nov 10, 2020 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Concord Biotech Ltd | TACROLIMUS | tacrolimus | CAPSULE;ORAL | 213112-002 | Nov 10, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.